TY - JOUR
AU - C. Miller-Rosales
AU - S. H. Busch
AU - E. R. Meara
AU - A. King
AU - T. A. D'Aunno
AU - C. H. Colla
A1 - 
AB - Medications for opioid use disorder (MOUD) remain highly inaccessible despite demonstrated effectiveness. We examine the extent of screening for opioid use and availability of MOUD in a national cross-section of multi-physician primary care and multispecialty practices. Drawing on an existing framework to characterize the internal and environmental context, we assess socio-technical, organizational-managerial, market-based, and state-regulation factors associated with the use of opioid screening and offering of MOUD in a practice. A total of 26.2% of practices offered MOUD, while 69.4% of practices screened for opioid use. Having advanced health information technology functionality was positively associated with both screening for opioid use and offering MOUD in a practice, while access to on-site behavioral clinicians was positively associated with offering MOUD in adjusted models. These results suggest that improving access to information and expertise may enable physician practices to respond more effectively to the nation's ongoing opioid epidemic.
AD - Harvard Medical School, Boston, MA, USA.; Yale School of Public Health, New Haven, CT, USA.; Harvard T.H. Chan School of Public Health, Boston, MA, USA.; The Dartmouth Institute for Health Policy & Clinical Practice, Lebanon, NH, USA.; New York University, New York City, USA.; Congressional Budget Office, Washington, DC, USA.
AN - 37036056
BT - Med Care Res Rev
C5 - Opioids & Substance Use; Education & Workforce
CP - 4
DA - Aug
DO - 10.1177/10775587231162681
DP - NLM
ET - 20230410
IS - 4
JF - Med Care Res Rev
LA - eng
N2 - Medications for opioid use disorder (MOUD) remain highly inaccessible despite demonstrated effectiveness. We examine the extent of screening for opioid use and availability of MOUD in a national cross-section of multi-physician primary care and multispecialty practices. Drawing on an existing framework to characterize the internal and environmental context, we assess socio-technical, organizational-managerial, market-based, and state-regulation factors associated with the use of opioid screening and offering of MOUD in a practice. A total of 26.2% of practices offered MOUD, while 69.4% of practices screened for opioid use. Having advanced health information technology functionality was positively associated with both screening for opioid use and offering MOUD in a practice, while access to on-site behavioral clinicians was positively associated with offering MOUD in adjusted models. These results suggest that improving access to information and expertise may enable physician practices to respond more effectively to the nation's ongoing opioid epidemic.
PY - 2023
SN - 1077-5587 (Print); 1077-5587
SP - 410
EP - 422+
ST - Internal and Environmental Predictors of Physician Practice Use of Screening and Medications for Opioid Use Disorders
T1 - Internal and Environmental Predictors of Physician Practice Use of Screening and Medications for Opioid Use Disorders
T2 - Med Care Res Rev
TI - Internal and Environmental Predictors of Physician Practice Use of Screening and Medications for Opioid Use Disorders
U1 - Opioids & Substance Use; Education & Workforce
U3 - 10.1177/10775587231162681
VL - 80
VO - 1077-5587 (Print); 1077-5587
Y1 - 2023
ER -